Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
PUT
AGNC Investment
AGNC
$12.8B
| $7.67M | ﹤0.01% |
392,400
+100,300
| +34% | +$1.97M |
|
|
SLCA
1752
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $7.67M | ﹤0.01% |
164,674
-14,988
| -8% | -$584K |
|
1753
PUT
Icahn Enterprises
IEP
$4.84B
| $7.64M | ﹤0.01% |
151,100
-60,300
| -29% | -$3.18M |
|
|
OA
1754
PUT
DELISTED
Orbital ATK, Inc.
OA
| $7.64M | ﹤0.01% |
100,200
+70,900
| +242% | +$5.65M |
|
|
AKRX
1755
PUT
DELISTED
Akorn Inc
AKRX
| $7.63M | ﹤0.01% |
279,900
+78,000
| +39% | +$2.31M |
|
1756
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.4B
| $7.63M | ﹤0.01% |
289,160
+94,284
| +48% | +$2.44M |
|
|
PAY
1757
PUT
DELISTED
Verifone Systems Inc
PAY
| $7.62M | ﹤0.01% |
484,200
+59,600
| +14% | +$1.08M |
|
1758
iShares MSCI India ETF
INDA
$6.64B
| $7.6M | ﹤0.01% |
+258,531
| New | +$7.58M |
|
|
JKS
1759
CALL
JinkoSolar
JKS
$715M
| $7.6M | ﹤0.01% |
481,100
-60,900
| -11% | -$1.11M |
|
|
TSL
1760
DELISTED
Trina Solar Limited
TSL
| $7.6M | ﹤0.01% |
741,771
+713,738
| +2,546% | +$7M |
|
1761
PUT
Becton Dickinson
BDX
$51.8B
| $7.58M | ﹤0.01% |
43,255
-43,358
| -50% | -$7.41M |
|
|
AMJ
1762
PUT
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $7.58M | ﹤0.01% |
240,800
+105,700
| +78% | +$3.33M |
|
1763
CALL
AllianceBernstein
AB
$3.43B
| $7.57M | ﹤0.01% |
332,000
+92,200
| +38% | +$2.09M |
|
1764
PUT
Community Health Systems
CYH
$412M
| $7.56M | ﹤0.01% |
654,900
+262,500
| +67% | +$3.03M |
|
1765
PUT
Pentair
PNR
$10B
| $7.55M | ﹤0.01% |
175,106
-60,752
| -26% | -$2.56M |
|
1766
CALL
Kinross Gold
KGC
$38.3B
| $7.55M | ﹤0.01% |
1,793,800
+65,200
| +4% | +$314K |
|
1767
Ovintiv
OVV
$17.8B
| $7.55M | ﹤0.01% |
144,129
+95,143
| +194% | +$4.27M |
|
1768
Wolfspeed
WOLF
$1.4B
| $7.54M | ﹤0.01% |
293,058
+230,578
| +369% | +$5.96M |
|
1769
CALL
Markel Group
MKL
$22.5B
| $7.52M | ﹤0.01% |
8,100
+3,200
| +65% | +$2.99M |
|
1770
CALL
Liberty Global Class C
LBTYK
$3.58B
| $7.52M | ﹤0.01% |
227,600
+69,800
| +44% | +$2.15M |
|
|
HTZ
1771
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $7.5M | ﹤0.01% |
+215,044
| New | +$9M |
|
1772
PUT
O'Reilly Automotive
ORLY
$72.4B
| $7.48M | ﹤0.01% |
400,500
-570,000
| -59% | -$10.7M |
|
|
CPHD
1773
PUT
DELISTED
Cepheid Inc
CPHD
| $7.47M | ﹤0.01% |
141,700
+121,300
| +595% | +$4.83M |
|
|
1774
AGNC Investment
AGNC
$12.8B
| $7.46M | ﹤0.01% |
+381,684
| New | +$7.48M |
|
|
CTXS
1775
PUT
DELISTED
Citrix Systems Inc
CTXS
| $7.46M | ﹤0.01% |
109,883
+12,056
| +12% | +$821K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.